The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

Diabetic macular edema remains an important cause of vision loss among patients with diabetes mellitus. Improved control of blood pressure and blood sugar, as well as photocoagulation, are ...

Diabetic macular edema can result in low vision or vision loss. Early treatment can help preserve vision longer. Diabetic macular edema (DME) is a complication of diabetes. Over time, high blood ...

Vision loss associated with DR primarily occurs due to diabetic macular edema (DME) and maculopathy, and the sequelae of proliferative DR (PDR): DME results in slowly developing moderate vision ...

macular edema caused by a blockage in the retinal vein diabetic retinopathy diabetic macular edema Eylea is also used to treat retinopathy of prematurity, an eye condition that can affect ...

today announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema (DME). “OCU200 has the potential to change the treatment landscape for DME ...